rx 821002 has been researched along with calcimycin in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
---|---|---|---|---|---|
317 | 0 | 45 | 11,946 | 40 | 444 |
Protein | Taxonomy | rx 821002 (IC50) | calcimycin (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 1.41 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cussac, D; Denis, C; Flordellis, C; Gales, C; Paris, H; Schaak, S | 1 |
1 other study(ies) available for rx 821002 and calcimycin
Article | Year |
---|---|
alpha(2B)-Adrenergic receptors activate MAPK and modulate proliferation of primary cultured proximal tubule cells.
Topics: Adrenergic alpha-Antagonists; Animals; Arachidonic Acid; Calcimycin; Cell Division; Cell Line; Cell Membrane; Cells, Cultured; Enzyme Activation; Epinephrine; Humans; Idazoxan; Ionophores; Kidney Tubules, Proximal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphorylation; Protein Kinase C; Quinolizines; Rats; Receptors, Adrenergic, alpha-2; Signal Transduction; Tritium; Virulence Factors, Bordetella | 2002 |